CRISPR Therapeutics (CRSP) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

91
on a 30–98 scale
STRONG BUY
$42.62last close
+15score vs prior day
75–91range since 10-12
-17.3%price since 10-12

The entry score measures one thing: how far CRISPR Therapeutics's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, CRISPR Therapeutics's price sits 2.69 ATR below its 20-day average ($49.66); it trades below its 200-day average ($52.58); its 14-day RSI is 31; it has moved -13.46% over 20 sessions; our regime filter classifies it as no confirmed trend.

Falling-knife flag: this Buy Zone score comes on top of a -26.67% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.

Is CRISPR Therapeutics (CRSP) a buy right now?

CRISPR Therapeutics scores 91/98 (Strong Buy) as of 2026-11-12; it is 31.1% below its 52-week high of $61.89; it is below its 200-day average; it moved -14.88% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. Caution: this Strong Buy comes right after a 10%+ drop in a week. In our own archive, that setup has usually been early (about −3% average over the next 5 sessions this autumn). It also carries a falling-knife flag (down 26.67% over ~60 sessions). Not investment advice. See the audit.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1291+15$42.62
2026-11-0676-4$50.07
2026-11-0580+3$48.56
2026-11-0477+0$51.78
2026-11-0377-2$49.99
2026-11-0279+3$49.99
2026-10-2976-1$54.26
2026-10-2877+2$54.11
2026-10-2775-9$51.47
2026-10-2684+2$49.01
2026-10-2382-1$49.39
2026-10-2283+3$49.99

Related stocks

See today's full rankings + entry plan for CRSP →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.